GRANO, MARIA
 Distribuzione geografica
Continente #
NA - Nord America 140
EU - Europa 120
AS - Asia 7
Totale 267
Nazione #
US - Stati Uniti d'America 140
IE - Irlanda 42
IT - Italia 41
SE - Svezia 19
UA - Ucraina 8
CN - Cina 5
FR - Francia 5
DE - Germania 2
FI - Finlandia 2
GB - Regno Unito 1
IN - India 1
SG - Singapore 1
Totale 267
Città #
Dublin 42
Boardman 20
Chandler 18
Nyköping 16
Bari 13
Ashburn 8
San Severo 6
Jacksonville 5
Rome 4
Malden 3
Princeton 3
Dearborn 2
Douai 2
Helsinki 2
New York 2
Paris 2
Seattle 2
Turin 2
Wilmington 2
Hangzhou 1
Kunming 1
London 1
Los Angeles 1
Milan 1
Modena 1
Modugno 1
Nanchang 1
Pune 1
Redmond 1
Shenyang 1
Tianjin 1
Totale 166
Nome #
Impairment of Bone Remodeling in LIGHT/TNFSF14-Deficient Mice 60
Antidepressant Effect of Intermittent Long‐Term Systemic Administration of Irisin in Mice 47
The Myokine Irisin Promotes Osteogenic Differentiation of Dental Bud-Derived MSCs 38
Irisin and Secondary Osteoporosis in Humans 38
Irisin Modulates Inflammatory, Angiogenic, and Osteogenic Factors during Fracture Healing 22
Irisin levels correlate with bone mineral density in soccer players 11
Vitamin D Increases Irisin Serum Levels and the Expression of Its Precursor in Skeletal Muscle 10
Time-dependent unloading effects on muscle and bone and involvement of FNDC5/irisin axis 9
LIGHT/TNFSF14 as a new biomarker of bone disease in multiple myeloma patients experiencing therapeutic regimens 9
High irisin levels are associated with better glycemic control and bone health in children with Type 1 diabetes 9
Impact of 10-day bed rest on serum levels of irisin and markers of musculoskeletal metabolism 8
Irisin Protects against Loss of Trabecular Bone Mass and Strength in Adult Ovariectomized Mice by Stimulating Osteoblast Activity 8
Once-Daily Subcutaneous Irisin Administration Mitigates Depression- and Anxiety-like Behavior in Young Mice 8
Circulating Irisin Levels in Patients with Chronic Plaque Psoriasis 7
Myokines and Osteokines in the Pathogenesis of Muscle and Bone Diseases 7
Short-Term Irisin Treatment Enhanced Neurotrophin Expression Differently in the Hippocampus and the Prefrontal Cortex of Young Mice 7
In Reply to the Letter to the Editor: Involvement of Irisin in Age-Related Osteoporosis and Its Inhibitory Effect on the Senescent Marker p21 in Osteoblasts 7
Irisin serum levels are positively correlated with bone mineral status in a population of healthy children 6
Irisin levels correlate with bone mineral density in soccer players 6
Deletion of the Transcription Factor PGC-1α in Mice Negatively Regulates Bone Mass 6
Irisin Prevents Disuse-Induced Osteocyte Apoptosis 5
Irisin and Bone: From Preclinical Studies to the Evaluation of Its Circulating Levels in Different Populations of Human Subjects 5
Systemic Administration of Recombinant Irisin Accelerates Fracture Healing in Mice 5
Irisin Correlates Positively With BMD in a Cohort of Older Adult Patients and Downregulates the Senescent Marker p21 in Osteoblasts 4
Effects of sweet cherry polyphenols on enhanced osteoclastogenesis associated with childhood obesity 4
Shedding “light” on the link between bone and fat in obese children and adolescents 4
LIGHT/TNFSF14 regulates estrogen deficiency-induced bone loss 4
Irisin Serum Levels and Skeletal Muscle Assessment in a Cohort of Charcot-Marie-Tooth Patients 3
Totale 357
Categoria #
all - tutte 3.822
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.822


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20209 2 1 0 0 1 2 1 0 1 0 1 0
2020/202114 1 0 2 0 1 0 1 0 1 3 2 3
2021/202223 0 0 0 0 1 0 2 1 8 5 1 5
2022/2023168 6 3 7 4 5 10 0 16 57 6 53 1
2023/2024134 6 19 18 17 10 8 21 2 3 1 8 21
Totale 357